INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "PREDICTING RESPONSE TO NEOADJUVANT TREATMENT IN NON-SMALL CELL LUNG CANCER"

GENEVA, April 28 -- ASTRAZENECA AB (SE-151-85 Sodertalje) filed a patent application (PCT/IB2024/060194) for "PREDICTING RESPONSE TO NEOADJUVANT TREATMENT IN NON-SMALL CELL LUNG CANCER" on Oct 17, 2024. With publication no. WO/2025/083600, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GALE, Davina (c/o AstraZeneca UK Limited1 Francis Crick AvenueCambridge Biomedical CampusCambridge Cambridgeshire CB2 0AA), ZHU, Zhou (c/o AstraZeneca Pharmaceuticals LP1800 Concord PikeP.O. Box 15437Wilmington, Delaware 19850-5437), LAI, ...